The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The digital health unicorn sells its chronic condition management and musculoskeletal programs to employers and health plans ...

Recent research out of Cornell University showed that GLP-1 users' grocery bills have been reduced by as much as 8.6% — with ...

GLP-1 agonist medications, originally designed to ... GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in the small intestine, which regulates key functions ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.